Cancer Biologics Market (By Drug Class: Monoclonal Antibodies, Cancer Growth Inhibitors, Vaccines, Recombinants Proteins, CAR-T Cells, Angiogenesis Inhibitors, Interleukins, Interferons, Gene Therapy, Others; By Applications: Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Gastric Cancer, Ovarian Cancer, Skin Cancer, Liver Cancer, Others; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global cancer biologics market size was valued at USD 102.01 billion in 2023 and is anticipated to reach around USD 214.59 billion by 2033, growing at a CAGR of 7.12% from 2024 to 2033.